Archive:
On the occasion of the event “AMNOG - a brake on innovation or a necessary correction?”, organized by the two pharmaceutical companies Boehringer and Lilly, which cooperate in the diabetes sector, Prof. Dr. Beate Kretschmer, Head of Health Care Strategy at Lilly Deutschland GmbH, and Ralf Gorniak, Managing Director of Boehringer Ingelheim Deutschland GmbH, give speeches and answers. The focus was not on looking back, but rather on looking forward, especially in view of the current G-BA resolution (see www.m-vf.de): What can be done better?
24.02.2012
Das Unternehmen Roche Diagnostics Deutschland veranstaltet seit zwei Jahren das wissenschaftliche Symposium „Diabetes Mediendialog“ in Fortführung der „Elmauer Gespräche“. In diesem Jahr stand das Metathema „Diabetes Management“ mit der Fragestellung „Eine unterschätzte Innovation?“ im Fokus der Veranstaltung, zu der rund 50 Fach- und Publikumsjournalisten gekommen waren. Das Programm spannte sich von der Darstellung aktueller Studienergebnisse über das Diabetes Management im Praxisprozess bis hin zur Betrachtung der ökonomischen Bedeutung aus Sicht einer Krankenkasse sowie der Fragestellung, welche Innovationshemmnisse die Umsetzung neuer Ideen in der Medizin generell entgegenstehen.
24.02.2012
It has long been known that treating diabetes is one of the most difficult of all diseases. On the one hand, this is because the person affected by diabetes does not feel anything for a very long time, which does not necessarily have a positive effect on compliance. With diabetes, as with many other indications, the earlier the disease is diagnosed and the sooner adequate therapy - accompanied by lifestyle changes - is initiated, the higher the chances of success in leading a symptom-free life for as long as possible. This requires, on the one hand, the insight to change one's lifestyle, secondly, adequate medication and, thirdly, the possibility of being able to take influence early on, quickly and in a timely manner. It only offers blood sugar self-monitoring, with the results of which a diabetic can control his diabetes. However, this individual self-management must be supplemented by cross-sector diabetes management, as was the focus of the “Diabetes Media Dialogue”, which was once again organized by the company Roche Diagnostics, which is itself embarking on the path from a diagnostic provider to a diabetes management provider has.
24.02.2012
Wie in Nordrhein-Westfalen das neue sektorübergreifende Planungsgremium („ein Kaffeekränzchen“) eingeführt wird, was sie von der neuen vierten Säule der ambulanten spezialfachärztlichen Versorgung („in Gänze überflüssig“) hält und wo sie im GKVVersorgungsstrukturgesetz Nachbesserungsbedarf („wir brauchen bedarfsgerechte Arztsitzverteilungen“) sieht, beschreibt die Gesundheitsministerin von NRW, Barbara Steffens (MdL, Mitglied von BÜNDNIS 90/DIE GRÜNEN) im Titelinterview von „Monitor Versorgungsforschung“. Ihr geht es vor allem um ein zukunftssicheres Versorgungssystem, das auf tatsächlichen Bedarfen, nicht auf hochgerechneten „ausgewürftelten“ Bedarfszahlen basiert und in dem ein neues sektorübergreifendes Miteinander und gemeinsame Verantwortung Einzug hält.
24.02.2012
In its judgments of June 21, 2011 (ref.: B 1 KR 14/10 R and B 1 KR 21/10 R), the Federal Social Court (BSG) decided for the first time on the approval of structured treatment programs to be granted by the Federal Insurance Office (BVA). There is no legal definition of the term “structured treatment program”, nor is there a legal definition of the term “disease management program”, abbreviated DMP, which is often used by the BSG and has the same content.
24.02.2012
Series: Health services research in the German federal states (Part 1)
15.02.2012
Providing care for people with diabetes is and remains a challenge. Type 2 diabetes is a global epidemic. The International Diabetes Federation projects 440 million people will be affected by 2030. That would be almost double the number of people affected compared to 2006. At the "3rd National Workshop on Diabetes Care," hosted by the IGES Institute in Berlin, experts addressed this issue […]
15.02.2012
There is no legal obligation for health services research under the AMNOG. Nevertheless, health services research is becoming increasingly important even in the era of AMNOG. This is particularly evident in light of the discussion surrounding benefit assessments in the area of the so-called existing market. The term "existing market" describes active substances that were approved before 2011 and still enjoy data protection. This article uses individual […]
01.02.2012
Less centralism, more regionalism – these were the core demands of the board of the Bavarian Association of Statutory Health Insurance Physicians (KVB) for the Statutory Health Insurance Care Structure Act, which came into force at the beginning of 2012. Dr. […] explains how the KVB intends to implement these requirements and what the future design of outpatient care in Bavaria should look like – namely, one that is as individualized as possible and does justice to regional peculiarities.
01.02.2012
Prof. Dr. Holger Pfaff and Prof. Dr. Sebastian Harder in the cover interview